The Impact of Renal Impairment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation With Melphalan Conditioning.

Ursu, Sorana G; Maples, Samantha; Williams, Kiersten J; Patrus, Gina; Samhouri, Yazan; Fazal, Salman; Mewawalla, Prerna; Sadashiv, Santhosh

Ursu, Sorana G; Maples, Samantha; Williams, Kiersten J; Patrus, Gina; Samhouri, Yazan; Fazal, Salman; Mewawalla, Prerna; Sadashiv, Santhosh.

Afiliación

Ursu SG; Division of Hematology/Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15224, USA.
Maples S; Division of Hematology/Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15224, USA.
Williams KJ; Division of Hematology/Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15224, USA.
Patrus G; Division of Hematology/Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15224, USA.
Samhouri Y; Division of Hematology/Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15224, USA.
Fazal S; Division of Hematology/Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15224, USA.
Mewawalla P; Division of Hematology/Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15224, USA.
Sadashiv S; Division of Hematology/Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA 15224, USA.

J Hematol ; 12(5): 201-207, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37936977

Palabras clave

Autologous stem cell transplantation; Melphalan; Renal impairment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Hematol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google